Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 17, Number 9—September 2011
Research

Central Venous Catheter–associated Nocardia Bacteremia in Cancer Patients

Fadi Al Akhrass, Ray Hachem, Jamal A. Mohamed, Jeffrey J. Tarrand, Dimitrios P. Kontoyiannis, Jyotsna Chandra, Mahmoud Ghannoum, Souha Haydoura, Ann Marie Chaftari, and Issam RaadComments to Author 
Author affiliations: Author affiliations: The University of Texas MD Anderson Cancer Center, Houston, Texas, USA (F. Al Akhrass, R. Hachem, J.A. Mohamed, J. Tarrand, D.P. Kontoyiannis, A.M. Chaftari, I. Raad); Case Western Reserve University, Cleveland, Ohio, USA (J. Chandra, M. Ghannoum); University Hospitals Case Medical Center, Cleveland (J. Chandra, M. Ghannoum); Kansas University School of Medicine, Wichita, Kansas, USA (S. Haydoura)

Main Article

Table 2

Diagnostic and microbiologic profile for 10 cases of Nocardia CLABSI, The University of Texas MD Anderson Cancer Center, January 1998–March 2010*

CLABSI case no. Diagnostic criteria CRBSI
1 Differential quantitative blood culture (CVC >1,000 CFU/mL; peri = 3 CFU/mL) and quantitative catheter tip culture (103 CFU/tip) Definite
2 Positive peripheral blood culture with positive semi-quantitative catheter tip culture (>15 CFU/tip) Definite
3 Differential quantitative blood culture (CVC >1,000 CFUs/mL; peri = 1 CFU/mL) Definite
4 CVC blood culture positive with positive semiquantitative catheter tip culture (>15 CFU/tip) Definite
5 Differential quantitative blood culture (CVC >1,000 CFU/mL; peri = 1 CFU/mL) Definite
6 Positive peripheral and CVC blood cultures with positive quantitative catheter tip culture (4,000 CFU/tip) Definite
7 Differential quantitative blood culture (CVC >1,000 CFU/mL; peri = 20 CFUs/mL) and positive quantitative catheter tip culture (4,000 CFU/tip) Definite
8 Positive peripheral and CVC blood culture but negative catheter tip culture Probable
9 Positive peripheral and CVC blood culture but negative catheter tip culture Probable
10 Positive CVC and peripheral blood culture but negative catheter tip culture Probable

*CLABSI, central line–associated bloodstream infection; CRBSI, catheter-related bloodstream infection, defined according to Infectious Disease Society of America guidelines (10); CVC, central venous catheter; peri, peripheral. CVC values indicate blood for culture collected from CVC; peri values indicate blood for culture collected from peripheral vessel.

Main Article

References
  1. Brown  JM, McNeil  M. Nocardia, Rhodococcus, Gordonia, Actinomadura, Streptomyces, and other aerobic actinomycetes. In: L Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, editors. Manual of clinical microbiology, 8th ed. Washington: American Society for Microbiology; 2003. p. 370–98.
  2. Lerner  PI. Nocardiosis. Clin Infect Dis. 1996;22:891–903, quiz 904–5. DOIPubMedGoogle Scholar
  3. Beaman  BL, Beaman  L. Nocardia species: host–parasite relationships. Clin Microbiol Rev. 1994;7:213–64.PubMedGoogle Scholar
  4. McNeil  MM, Brown  JM. The medically important aerobic actinomycetes: epidemiology and microbiology. Clin Microbiol Rev. 1994;7:357–417.PubMedGoogle Scholar
  5. Kontoyiannis  DP, Ruoff  K, Hooper  DC. Nocardia bacteremia. Report of 4 cases and review of the literature. Medicine (Baltimore). 1998;77:255–67. DOIPubMedGoogle Scholar
  6. Lui  WY, Lee  AC, Que  TL. Central venous catheter–associated Nocardia bacteremia. Clin Infect Dis. 2001;33:1613–4. DOIPubMedGoogle Scholar
  7. Torres  HA, Reddy  BT, Raad  II, Tarrand  J, Bodey  GP, Hanna  HA, Nocardiosis in cancer patients. Medicine (Baltimore). 2002;81:388–97. DOIPubMedGoogle Scholar
  8. Kontoyiannis  DP, Jacobson  KL, Whimbey  EE, Rolston  KV, Raad  II. Central venous catheter–associated Nocardia bacteremia: an unusual manifestation of nocardiosis. Clin Infect Dis. 2000;31:617–8. DOIPubMedGoogle Scholar
  9. Centers for Disease Control and Prevention. Central line–associated bloodstream infection (CLABSI) event [cited 2011 Jun 1]. http://www.cdc.gov/nhsn/pdfs/pscmanual/4psc_clabscurrent.pdf
  10. Mermel  LA, Allon  M, Bouza  E, Craven  DE, Flynn  P, O’Grady  NP, Clinical practice guidelines for the diagnosis and management of intravascular catheter–related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49:1–45. DOIPubMedGoogle Scholar
  11. Woo  PC, Lau  SK, Teng  JL, Tse  H, Yuen  KY. Then and now: use of 16S rDNA gene sequencing for bacterial identification and discovery of novel bacteria in clinical microbiology laboratories. Clin Microbiol Infect. 2008;14:908–34. DOIPubMedGoogle Scholar
  12. Steingrube  VA, Brown  BA, Gibson  JL, Wilson  RW, Brown  J, Blacklock  Z, DNA amplification and restriction endonuclease analysis for differentiation of 12 species and taxa of Nocardia, including recognition of four new taxa within the Nocardia asteroides complex. J Clin Microbiol. 1995;33:3096–101.PubMedGoogle Scholar
  13. Clinical and Laboratory Standards Institute. Susceptibility testing of Mycobacteria, Nocardiae, and other aerobic actinomycetes; approved standard. NCCLS document M24-A. Wayne (PA): The Institute; 2003.
  14. Hanna  H, Bahna  P, Reitzel  R, Dvorak  T, Chaiban  G, Hachem  R, Comparative in vitro efficacies and antimicrobial durabilities of novel antimicrobial central venous catheters. Antimicrob Agents Chemother. 2006;50:3283–8. DOIPubMedGoogle Scholar
  15. Raad  I, Hanna  H, Dvorak  T, Chaiban  G, Hachem  R. Optimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofilm. Antimicrob Agents Chemother. 2007;51:78–83. DOIPubMedGoogle Scholar
  16. Chandra  J, Mukherjee  PK, Ghannoum  MA. In vitro growth and analysis of Candida biofilms. Nat Protoc. 2008;3:1909–24. DOIPubMedGoogle Scholar
  17. Wallace  RJ Jr, Tsukamura  M, Brown  BA, Brown  J, Steingrube  VA, Zhang  YS, Cefotaxime-resistant Nocardia asteroides strains are isolates of the controversial species Nocardia farcinica. J Clin Microbiol. 1990;28:2726–32.PubMedGoogle Scholar
  18. Conville  PS, Brown  JM, Steigerwalt  AG, Lee  JW, Byrer  DE, Anderson  VL, Nocardia veterana as a pathogen in North American patients. J Clin Microbiol. 2003;41:2560–8. DOIPubMedGoogle Scholar
  19. Roth  A, Andrees  S, Kroppenstedt  RM, Harmsen  D, Mauch  H. Phylogeny of the genus Nocardia based on reassessed 16S rRNA gene sequences reveals underspeciation and division of strains classified as Nocardia asteroides into three established species and two unnamed taxons. J Clin Microbiol. 2003;41:851–6. DOIPubMedGoogle Scholar
  20. Wallace  RJ Jr, Brown  BA, Tsukamura  M, Brown  JM, Onyi  GO. Clinical and laboratory features of Nocardia nova. J Clin Microbiol. 1991;29:2407–11.PubMedGoogle Scholar
  21. Tuo  MH, Tsai  YH, Tseng  HK, Wang  WS, Liu  CP, Lee  CM. Clinical experiences of pulmonary and bloodstream nocardiosis in two tertiary care hospitals in northern Taiwan, 2000–2004. J Microbiol Immunol Infect. 2008;41:130–6.PubMedGoogle Scholar
  22. Lai  CH, Chi  CY, Chen  HP, Lai  CJ, Fung  CP, Liu  CY. Port-A catheter-associated Nocardia bacteremia detected by gallium inflammation scan: a case report and literature review. Scand J Infect Dis. 2004;36:775–7.PubMedGoogle Scholar
  23. Saubolle  MA, Sussland  D. Nocardiosis: review of clinical and laboratory experience. J Clin Microbiol. 2003;41:4497–501. DOIPubMedGoogle Scholar
  24. Benoit  JL, Carandang  G, Sitrin  M, Arnow  PM. Intraluminal antibiotic treatment of central venous catheter infections in patients receiving parenteral nutrition at home. Clin Infect Dis. 1995;21:1286–8. DOIPubMedGoogle Scholar
  25. Koldehoff  M, Zakrzewski  JL. Taurolidine is effective in the treatment of central venous catheter–related bloodstream infections in cancer patients. Int J Antimicrob Agents. 2004;24:491–5. DOIPubMedGoogle Scholar
  26. Raad  I, Buzaid  A, Rhyne  J, Hachem  R, Darouiche  R, Safar  H, Minocycline and ethylenediaminetetraacetate for the prevention of recurrent vascular catheter infections. Clin Infect Dis. 1997;25:149–51. DOIPubMedGoogle Scholar
  27. Root  JL, McIntyre  OR, Jacobs  NJ, Daghlian  CP. Inhibitory effect of disodium EDTA upon the growth of Staphylococcus epidermidis in vitro: relation to infection prophylaxis of Hickman catheters. Antimicrob Agents Chemother. 1988;32:1627–31.PubMedGoogle Scholar
  28. Biehle  JR, Cavalieri  SJ, Saubolle  MA, Getsinger  LJ. Comparative evaluation of the E test for susceptibility testing of Nocardia species. Diagn Microbiol Infect Dis. 1994;19:101–10. DOIPubMedGoogle Scholar
  29. Ambaye  A, Kohner  PC, Wollan  PC, Roberts  KL, Roberts  GD, Cockerill  FR III. Comparison of agar dilution, broth microdilution, disk diffusion, E-test, and BACTEC radiometric methods for antimicrobial susceptibility testing of clinical isolates of the Nocardia asteroides complex. J Clin Microbiol. 1997;35:847–52.PubMedGoogle Scholar
  30. Gomez-Flores  A, Welsh  O, Said-Fernandez  S, Lozano-Garza  G, Tavarez-Alejandro  RE, Vera-Cabrera  L. In vitro and in vivo activities of antimicrobials against Nocardia brasiliensis. Antimicrob Agents Chemother. 2004;48:832–7. DOIPubMedGoogle Scholar
  31. Brown-Elliott  BA, Ward  SC, Crist  CJ, Mann  LB, Wilson  RW, Wallace  RJ Jr. In vitro activities of linezolid against multiple Nocardia species. Antimicrob Agents Chemother. 2001;45:1295–7. DOIPubMedGoogle Scholar
  32. Glupczynski  Y, Berhin  C, Janssens  M, Wauters  G. Determination of antimicrobial susceptibility patterns of Nocardia spp. from clinical specimens by Etest. Clin Microbiol Infect. 2006;12:905–12. DOIPubMedGoogle Scholar
  33. Wallace  RJ Jr, Steele  LC, Sumter  G, Smith  JM. Antimicrobial susceptibility patterns of Nocardia asteroides. Antimicrob Agents Chemother. 1988;32:1776–9.PubMedGoogle Scholar
  34. Tomlin  P, Sand  C, Rennie  RP. Evaluation of E test, disk diffusion and broth microdilution to establish tentative quality control limits and review susceptibility breakpoints for two aerobic actinomycetes. Diagn Microbiol Infect Dis. 2001;40:179–86. DOIPubMedGoogle Scholar

Main Article

Page created: September 06, 2011
Page updated: September 06, 2011
Page reviewed: September 06, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external